4//SEC Filing
Culwell Kelly 4
Accession 0001618835-21-000135
CIK 0001618835other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 4:26 PM ET
Size
4.9 KB
Accession
0001618835-21-000135
Insider Transaction Report
Form 4
Culwell Kelly
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2021-05-20$0.86/sh−42,061$36,172→ 273,390 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 20, 2021. No shares were sold in connection with this transaction.
Documents
Issuer
Evofem Biosciences, Inc.
CIK 0001618835
Entity typeother
Related Parties
1- filerCIK 0001726183
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 4:26 PM ET
- Size
- 4.9 KB